Literature DB >> 21442683

Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997-2007.

Kristiina Manderbacka1, Reijo Sund, Sari Koski, Ilmo Keskimäki, Marko Elovainio.   

Abstract

PURPOSE: The association between diabetes and depression is well demonstrated. Less is known about the trends in use of antidepressants in the rapidly growing population of diabetics. We examined trends in antidepressant medication use during 1997-2007 in Finland among persons with or without diabetes using register-based data on both diabetes and antidepressant use.
METHODS: The diabetes population was obtained from the FinDM II database including 50,027 persons with insulin treated (ITDM) and 346,290 persons with non-insulin treated diabetes (NITDM) identified from several administrative registers. Data on persons without diabetes were obtained from the yearly population statistics and their antidepressant use from the register for refunded prescription medicine costs covering all medicine purchases of non-institutionalised residents. Differences in trends and prevalence were examined using the binomial regression model.
RESULTS: Antidepressant use was more common among persons with diabetes in all age groups and each study year among both genders (prevalence ratios (RR) 1.4-2.2 for women and 1.7-2.2 for men). Prevalence was both higher (RR 2.0-2.2 women, 1.9-2.2 men), and increased more rapidly among younger persons with NITDM.
CONCLUSIONS: The use of register data linked using unique personal identifiers allowed us to identify a total cohort of persons with diabetes, to separate between ITDM and NITDM patients and to examine patterns of antidepressant use in populations with and without diabetes during an 11 year study period. Our results suggest that more attention should be focused on psychological well-being in those with diabetes and especially young people in risk of type 2 diabetes.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21442683     DOI: 10.1002/pds.2072

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

Review 1.  Global trends in diabetes complications: a review of current evidence.

Authors:  Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg
Journal:  Diabetologia       Date:  2018-08-31       Impact factor: 10.122

2.  Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study.

Authors:  T Lind; I Waernbaum; Y Berhan; G Dahlquist
Journal:  Diabetologia       Date:  2011-12-17       Impact factor: 10.122

3.  Antidepressant use and diabetes mellitus risk: a meta-analysis.

Authors:  Jae Moon Yoon; Eun-Geol Cho; Hyun-Ki Lee; Sang Min Park
Journal:  Korean J Fam Med       Date:  2013-07-24

4.  Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.

Authors:  Eva Haastrup; Katrine Grau; Jesper Eugen-Olsen; Christian Thorball; Lars Vedel Kessing; Henrik Ullum
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

Review 5.  Characterizing Multimorbidity from Type 2 Diabetes: Insights from Clustering Approaches.

Authors:  Meryem Cicek; James Buckley; Jonathan Pearson-Stuttard; Edward W Gregg
Journal:  Endocrinol Metab Clin North Am       Date:  2021-09       Impact factor: 4.741

6.  Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort.

Authors:  James A Black; Rebecca K Simmons; Clare E Boothby; Melanie J Davies; David Webb; Kamlesh Khunti; Gráinne H Long; Simon J Griffin
Journal:  BMJ Open Diabetes Res Care       Date:  2015-10-01

7.  Effects of different doses of doxepin on passive avoidance learning in rats.

Authors:  Mahsa Gharzi; Hamid R D Dolatabadi; Parham Reisi; Shaghayegh H Javanmard
Journal:  Adv Biomed Res       Date:  2013-07-30

8.  Effects of doxepin on brain-derived neurotrophic factor, tumor necrosis factor alpha, mitogen-activated protein kinase 14, and AKT1 genes expression in rat hippocampus.

Authors:  Nastaran Eidelkhani; Maryam Radahmadi; Mohammad Kazemi; Laleh Rafiee; Hojjatallah Alaei; Parham Reisi
Journal:  Adv Biomed Res       Date:  2015-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.